{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T06:26:52Z","timestamp":1760077612090,"version":"3.37.3"},"reference-count":25,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Peritoneal Malignancy Institute","award":["Charitable Fund","N\/A"],"award-info":[{"award-number":["Charitable Fund","N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Fear of cancer recurrence (FCR) is correlated with higher depression levels, worse quality of life and increased utilisation of healthcare services. There is no research on FCR in peritoneal malignancy (PM) patients\u2014a rare type of abdominal cancer. This study aims to explore the prevalence, trajectory, demographic and clinical characteristics that are associated with FCR and its relationship with quality of life in PM patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>This is a cross-sectional study. Validated measures will be used to collect data on the levels of FCR (Fear of Cancer Recurrence Inventory-Short Form) and quality of life (36-Item Short-Form Health Survey) of PM patients who have had surgery in the last 5\u2009years at the Peritoneal Malignancy Institute in Basingstoke Hospital (minimum N=260). Descriptive statistics, Pearson \u03c7<jats:sup>2<\/jats:sup> tests and correlational tests will be used to analyse the data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>Ethical approval was obtained from the HRA and Health and Care Research Wales (HCRW). The results of this study will be shared with the participants of this study, presented at conferences and PM patients\u2019 days in the form of presentations or posters, and published in a scientific journal.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The results of this exploratory study will be used to inform a multicentre observational study to explore the effect of FCR on PM patients\u2019 mental health (depression and anxiety), quality of life and healthcare utilisation which will inform a multicentre randomised controlled trial to assess the effectiveness of using evidenced-based interventions to lower FCR in PM patients.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2021-057294","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T03:16:57Z","timestamp":1644895017000},"page":"e057294","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): an observational study protocol"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8592-527X","authenticated-orcid":false,"given":"Rayan","family":"Taher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Vanderpuye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kandiah","family":"Chandrakumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"2022021419101310000_12.2.e057294.1","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.21037\/jgo-2020-01","article-title":"New insights in the pathology of peritoneal surface malignancy","volume":"12","author":"Carr","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"2022021419101310000_12.2.e057294.2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25642"},{"key":"2022021419101310000_12.2.e057294.3","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1245\/s10434-021-10093-z","article-title":"Managing recurrent pseudomyxoma peritonei in 430 patients after complete cytoreduction and HIPEC: a dilemma for patients and surgeons","volume":"28","author":"Ahmadi","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2022021419101310000_12.2.e057294.4","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000000719"},{"key":"2022021419101310000_12.2.e057294.5","doi-asserted-by":"crossref","first-page":"gov044","DOI":"10.1093\/gastro\/gov044","article-title":"Treatment of peritoneal metastases from colorectal cancer","volume":"3","author":"M\u00e4rz","year":"2015","journal-title":"Gastroenterol Rep"},{"key":"2022021419101310000_12.2.e057294.6","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","article-title":"Colorectal peritoneal metastases: optimal management review","volume":"25","author":"S\u00e1nchez-Hidalgo","year":"2019","journal-title":"World J Gastroenterol"},{"key":"2022021419101310000_12.2.e057294.7","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2019-105826"},{"key":"2022021419101310000_12.2.e057294.8","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1093\/bjs\/znaa126","article-title":"Correspondence to 'Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results'","volume":"108","author":"Chiu","year":"2021","journal-title":"Br J Surg"},{"key":"2022021419101310000_12.2.e057294.9","article-title":"Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for management of peritoneal metastases","volume":"4","author":"Zhu","year":"2013","journal-title":"J Gastrointest Oncol"},{"key":"2022021419101310000_12.2.e057294.10","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3114"},{"key":"2022021419101310000_12.2.e057294.11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-1"},{"key":"2022021419101310000_12.2.e057294.12","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-013-0272-z"},{"key":"2022021419101310000_12.2.e057294.13","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11764-015-0512-5","article-title":"Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation","volume":"10","author":"Fardell","year":"2016","journal-title":"J Cancer Surviv"},{"key":"2022021419101310000_12.2.e057294.14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00520-015-2808-4","article-title":"Fear of cancer recurrence in colorectal cancer survivors","volume":"24","author":"Custers","year":"2016","journal-title":"Support Care Cancer"},{"key":"2022021419101310000_12.2.e057294.15","first-page":"P 95","volume-title":"August). fear of cancer recurrence: an overview and Australian perspective. in cancer forum","volume":"39","author":"Butow","year":"2015"},{"key":"2022021419101310000_12.2.e057294.16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejon.2007.10.003","article-title":"A study to explore the patient's experience of peritoneal surface malignancies: pseudomyxoma peritonei","volume":"12","author":"Witham","year":"2008","journal-title":"Eur J Oncol Nurs"},{"key":"2022021419101310000_12.2.e057294.17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fpsyt.2019.00537","article-title":"Psychometric properties of the short form of the fear of cancer recurrence inventory (FCRI) in Chinese breast cancer survivors","volume":"10","author":"Peng","year":"2019","journal-title":"Front Psychiatry"},{"key":"2022021419101310000_12.2.e057294.18","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-015-0424-4"},{"key":"2022021419101310000_12.2.e057294.19","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2147\/PRBM.S231577","article-title":"Spotlight on the fear of cancer recurrence inventory (FCRI)","volume":"13","author":"Smith","year":"2020","journal-title":"Psychol Res Behav Manag"},{"key":"2022021419101310000_12.2.e057294.20","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.3390\/jcm9092969","article-title":"Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma","volume":"9","author":"Lynch","year":"2020","journal-title":"J Clin Med"},{"key":"2022021419101310000_12.2.e057294.21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.13175\/swjpcc082-16","article-title":"Obstructive sleep apnea and quality of life: comparison of the SAQLI, FOSQ, and SF-36 questionnaires","volume":"13","author":"Silva","year":"2016","journal-title":"Southwest J Pulm Crit Care"},{"key":"2022021419101310000_12.2.e057294.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-018-0933-8","article-title":"Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease","volume":"16","author":"Finkelstein","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"2022021419101310000_12.2.e057294.23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/lrb.2016.0035","article-title":"Sf-36 shows increased quality of life following complete reduction of postmastectomy lymphedema with liposuction","volume":"15","author":"Hoffner","year":"2017","journal-title":"Lymphat Res Biol"},{"key":"2022021419101310000_12.2.e057294.24","doi-asserted-by":"crossref","unstructured":"Cohen J . Statistical power analysis for the behavioral sciences. Academic press, 2013.","DOI":"10.4324\/9780203771587"},{"key":"2022021419101310000_12.2.e057294.25","first-page":"32","article-title":"Fear of cancer recurrence: a practical guide for clinicians","volume":"32","author":"Butow","year":"2018","journal-title":"Oncology"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-057294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T03:17:16Z","timestamp":1644895036000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-057294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,14]]},"published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1136\/bmjopen-2021-057294"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-057294","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}